ADAR1 Capital Management’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$184K Buy
+20,535
New +$140K 0.01% 265
2025
Q2
Sell
-1,675
Closed -$8.77K 232
2025
Q1
$8.77K Hold
1,675
﹤0.01% 196
2024
Q4
$12.9K Buy
1,675
+12
+0.7% +$101 ﹤0.01% 205
2024
Q3
$15.6K Buy
1,663
+263
+19% +$2.53K ﹤0.01% 247
2024
Q2
$15K Sell
1,400
-843
-38% -$11.4K ﹤0.01% 226
2024
Q1
$33.2K Buy
+2,243
New +$31.3K 0.01% 203

Other funds holding RLYB

ADAR1 Capital Management's RLYB Position: Q1 2026 in Review

ADAR1 Capital Management opened a new position in Rallybio (RLYB) in Q1 2026: 20,535 shares worth $184K. The stake represents 0.01% of the portfolio and ranks #265 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in RLYB as recently as Q1 2025.

ADAR1 Capital Management first reported a position in RLYB in Q1 2024 and has held it in 6 quarters since. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • ADAR1 Capital Management held 20,535 shares of Rallybio worth $184K as of Q1 2026.
  • Rallybio was a new ADAR1 Capital Management position in Q1 2026.
  • Rallybio made up 0.01% of ADAR1 Capital Management's portfolio in Q1 2026, its #265 holding.
  • ADAR1 Capital Management first reported a position in Rallybio in Q1 2024 and has held it in 6 quarters since.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.